LimaCorporate Breaks Ground for First On-site Hospital 3D Printing Facility

LimaCorporate Breaks Ground for First On-site Hospital 3D Printing Facility

by Medical

Global medical device company LimaCorporate has confirmed that it has started construction of its forthcoming on-site 3D printing facility at the Hospital for Special Surgery (HSS) in New York. First confirmed in January this year, the partners held a ground breaking ceremony at the site at the end of May. Building works are scheduled for completion by 2020, and the center itself is expected to be in operation early in the same year.

Materialise Buys Majority Stake in Engimplan, Expands Medical 3D Printing Business in Brazil

Materialise Buys Majority Stake in Engimplan, Expands Medical 3D Printing Business in Brazil

by Medical

Belgian software and 3D printing service provider Materialise has acquired a 75 percent stake in Engimplan, a Brazil-based medical device manufacturer. In this agreement, Materialise will apply its medical 3D printing expertise to Engimplan’s device portfolio. Together, the two companies will work to accelerate the introduction of 3D printed medical implants and instruments to the Brazilian market.

Candid and Carbon Partner to Produce Clear Aligners for Orthodontics

Candid and Carbon Partner to Produce Clear Aligners for Orthodontics

by Medical

3D-printed orthodontics have come a long way in the past three years, and Carbon and Candid’s new partnership to produce models for clear aligners that straighten teeth is grist for this mill. Carbon’s L1 printers and DLS process allow Candid to introduce Candid Pro, its “orthodontics-as-a-service” doctor-driven clear aligner therapy. This service offers customized, on-demand clear aligners designed specifically for dental and orthodontic practices. The entire service is delivered on Candid’s digital platform.

DDD Focuses on Healthcare after Solid-Organ Scaffolds’ Success

DDD Focuses on Healthcare after Solid-Organ Scaffolds’ Success

by Medical

3D Systems significantly expanded its focus on regenerative medicine and bioprinting solutions after reducing its workforce to concentrate on the healthcare AM sector. The expanded focus follows on great progress made in the development of 3D printing systems for solid-organ scaffolds. This progress is the product of collaboration between 3D Systems, United Therapeutics Corporation and UTC’s organ manufacturing and transplantation-focused subsidiary, Lung Biotechnology PBC. 3D Systems intends to leverage this work and accomplishments with other partners to invest, further develop and commercialize solutions for regenerative medicine. Applications of its R&D program include the development of non-solid organ applications requiring biologically sustainable vasculature.